Consumer Driven Health Care

Q2 is here and it's time for a benefits checkup: Do the benefits you offer truly provide for all aspects of an employee's wellbeing?

The city of Baltimore, which paid more than $11 million in 2023 for diabetes medications through its self-funded plan, is suing the drug manufacturers, for allegedly conspiring to artificially hike the price of insulin.

On Tuesday, the justices will hear arguments on whether to revoke mifepristone's approval and curtail its availability because the FDA imposed strict safety limits on who could prescribe and distribute it when it gave its approval.

The proliferation of advertising on social media for Ozempic, Wegovy and other weight loss drugs will be a key part of the upcoming "stomach paralysis" lawsuits against Novo Nordisk and Eli Lilly.

The weeks-long outage at Change Healthcare, which was hit with a cyberattack, could negatively impact the credit of smaller providers and pharmacies that depend on it for financial services, warns the credit rating agency.

The HHS rule, which mandates that health insurers not count copay assistance toward out-of-pocket costs, was struck down last fall, however, it is backfiring on patients with chronic diseases that need expensive drugs.